Novel glycidyl methacrylated dextrangelatin nanoparticles loaded with basic fibroblast growth factor: Formulation and characteristics

Drug Development and Industrial Pharmacy

Volumn 35, Issue 12, 2009, Pages 1419-1429

  Gu, Chunhu ^a   Zheng, Renhong ^a   Yang, Zhifu ^a   Wen, Aidong ^a   Wu, Hong ^b   Zhang, Hui ^b   Yi, Dinghua ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Basic fibrous growth factor; Dextran; Drug delivery system; Gelatin; Nanoparticle

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN TYPE 1; FIBRONECTIN; GELATIN; GLYCIDYLMETHACRYLATE; METHACRYLIC ACID DERIVATIVE; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIODEGRADABILITY; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; HYDROGEL; MESENCHYMAL STEM CELL; MOUSE; NANOENCAPSULATION; NONHUMAN; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; BONE MARROW CELLS; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; CROSS-LINKING REAGENTS; DEXTRANS; DRUG CARRIERS; EPOXY COMPOUNDS; FIBROBLAST GROWTH FACTOR 2; GELATIN; HYDROGELS; KINETICS; MESENCHYMAL STEM CELLS; METHACRYLATES; MICE; NANOPARTICLES; PARTICLE SIZE; WATER;

EID: 71049118145     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639040902988558     Document Type: Article

References (37)

1. Harvey C. (2005). Wound healing. Orthop Nurs, 24:143-157
2. Suh H. (2000). Tissue restoration, tissue engineering and regenerative medicine. Yonsei Med J, 41:681-684
3. Kumar R, Dutt K. (2006). Enhanced neurotrophin synthesis and molecular differentiation in non-transformed human retinal progenitor cells cultured in a rotating bioreactor. Tissue Eng, 12:141-158
4. Chayed S, Winnik FM. (2007). In vitro evaluation of the mucoadhesive properties of polysaccharide-based nanoparticulate oral drug delivery systems. Eur J Pharm Biopharm, 65:363-370
5. Hussein MZ, Nasir NM, Yahaya AH. (2008). Controlled release compound based on metanilate-layered double hydroxide nanohybrid. J Nanosci Nanotechnol, 8:5921-5928
6. Kim SS, Min SP, Oju J, Cha YC, Kim BS. (2006). Poly(lactide-coglycolide)/ hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials, 27:1399-1409
7. Young S, Wong M, Tabata Y, Mikos AG. (2005). Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release, 109:256-274
8. Stenekes RJH, Loebis AE, Fernandes CM, Crommelin DJA, Hennink WE. (2001). Degradable dextran microspheres for the controlled release of liposomes. Int J Pharm, 214:17-20
9. Kim IS, Jeong YI, Kim DH, Lee YH, Kim SH. (2001). Albumin release from biodegradable hydrogels composed of dextran and poly(ethylene glycol) macromer. Arch Pharm Res, 24:69-73.
10. Van Dijk-Wolthuis WNE, Franssen O, Talsma H, Van Steenbergen MJ, Kettenes-Van Den Bosch JJ, Hennink WE. (1995). Synthesis, characterization and polymerization of glycidyl methacrylate derivatized dextran. Macromolecules, 28:6317-6322
11. Cadée JA, de Groot CJ, Jiskoot W, Den Otter W, Hennink WE. (2002). Release of recombinant human interleukin-2 from dextran-based hydrogels. J Control Release, 78:1-13
12. Chen FM, Zhao YM, Wu H, Deng ZH, Wang QT, Zhou W, et al. (2006). Enhancement of periodontal tissue regeneration by locally controlled delivery of insulin-like growth factor-I from dextran-co-gelatin microspheres. J Control Release, 114:209-222
13. Chen FM, Wu ZF, Sun HH, Wu H, Xin SN, Wang QT, et al. (2006). Release of bioactive BMP from dextran-derived microspheres: A novel delivery concept. Int J Pharm, 307:23-32
14. Chen FM, Ma ZW, Dong GY, Wu ZF. (2009). Composite glycidyl methacrylated dextran (Dex-GMA)/gelatin nanoparticles for localized protein delivery. Acta Pharmacol Sin, 23:1-9
15. Panyam J, Labhasetwar V. (2003). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev, 55:329-347
16. Biondi M, Ungaro F, Quaglia F, Netti PA. (2008). Controlled drug delivery in tissue engineering. Adv Drug Deliv Rev, 60:229-242
17. Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. (2008). Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. J Control Release, 125:193-209
18. Jabr-Milane L, Van Vlerken L, Devalapally H, Shenoy D, Komareddy S, Bhavsar M. (2008). Multi-functional nanocarriers for targeted delivery of drugs and genes. J Control Release, 130:121-128
19. Kosmala JD, Henthorn DB, Brannon-Peppas L. (2000). Preparation of interpenetrating networks of gelatin and dextran as degradable biomaterials. Biomaterials, 21:2019-2023
20. Tang MH, Dou HJ, Sun K. (2006). One-step synthesis of dextran-based stable nanoparticles assisted by self-assembly. Polymer, 47:728-734
21. Zhang H, Gu CH, Wu H, Fan L, Li F, Yang F, et al. (2007). Immobilization of derivatized dextran nanoparticles on konjac glucomannan/chitosan film as a novel wound dressing. Biofactors, 30:227-240
22. Yamamoto M, Ikada Y, Tabata Y. (2001). Controlled release of growth factors based on biodegradation of gelatin hydrogel. J Biomater Sci Polym Ed, 12:77-88 (Pubitemid 32331415)
23. Kopen C, Prockop DJ, Phinney DG. (1999). Marrow stromal cells migrates throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA, 96:10711-10716
24. Landegren U. (1984). Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J Immunol Methods, 67:379-388
25. Kim SH, Chu CC. (2000). Synthesis and characterization of dextran methacrylate hydrogels and structural study by SEM. J Biomed Mater Res, 49:517-527
26. Reilly GC, Radin S, Chen AT, Ducheyne P. (2007). Differential alkaline phosphatase responses of rat and human bone marrow derived mesenchymal stem cells to 45S5 bioactive glass. Biomaterials, 28:4091-4097
27. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, et al. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest, 103:697-705
28. Shi X, Sitharaman B, Pham QP, Liang F, Wu K, Edward Billups W, et al. (2007). Fabrication of porous ultra-short single-walled carbon nanotube nanocomposite scaffolds for bone tissue engineering. Biomaterials, 28:4078-4090
29. Gospodarowizc N. (1991). Biological activities of fibroblast growth factor. Ann N Y Acad Sci, 638:1-8
30. McGee GS, Cavidson JM, Buckley A, Sommer A, Woodward SC, Aquino AM. (1988). Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res, 45:145-153
31. Kawaguchi H, Kurokawa T, Hanada K, Hiyama Y, Tamura M, Ogata E. (1994). Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocindiabetic rats. Endocrinology, 135:774-781
32. Trippel SB. (1995). Growth factor actions on articular cartilage. J Rheumatol Suppl, 22:129-132
33. Chan D, Lamande SR, Cole WG, Bateman JF. (1990). Regulation of procollagen synthesis and processing during ascorbate-induced extracellular matrix accumulation in vitro. Biochem J, 269:175-181
34. McCarthy JB, Vachhani B, Iida J. (1996). Cell adhesion to collagenous matrices. Biopolymers, 40:371-381
35. Eyre DR, Wu JJ, Fernandes RJ, Pietka TA, Weis MA. (2002). Recent developments in cartilage research: Matrix biology of the collagen II/IX/XI heterofibril network. Biochem Soc Trans, 30:893-899
36. Nagai T, Yamakawa N, Aota S, Yamada SS, Akiyama SK, Olden K, et al. (1991). Monoclonal antibody characterization of two distant sites required for function of the central cell-binding domain of fibronectin in cell adhesion, cell migration, and matrix assembly. J Cell Biol, 114:1295-1305
37. Akiyama SK, Yamada KM, Hayashi M. (1981). The structure of fibronectin and its role in cellular adhesion. J Supramol Struct Cell Biochem, 16:345-348